Literature DB >> 25243836

Psychological symptoms, smoking lapse behavior, and the mediating effects of nicotine withdrawal symptoms: A laboratory study.

Katherine J Ameringer1, Adam M Leventhal1.   

Abstract

The influence of psychological symptoms on smoking-lapse behavior is critical to understand. However, this relationship is obscured by comorbidity across multiple forms of psychological symptoms and their overlap with nicotine withdrawal. To address these challenges, we constructed a structural model of latent factors underlying 9 manifest scales of affective and behavioral symptoms and tested relations between latent factors and manifest scale residuals with nicotine withdrawal and smoking lapse in a laboratory analog task. Adult daily smokers (N = 286) completed a baseline session at which several forms of affective and behavioral symptoms were assessed and 2 experimental sessions (i.e., following 16 hr of smoking abstinence and following regular smoking), during which withdrawal symptoms and delay of smoking in exchange for monetary reinforcement, as an analogue for lapse propensity, were measured. A single second-order factor of general psychological maladjustment associated with more severe withdrawal-like symptoms, which in turn associated with shorter delay of smoking. The first-order factors, which tapped qualitatively unique domains of psychological symptoms (low positive affect, negative affect, disinhibition), and the manifest scale residuals provided little predictive power beyond the second-order factor with regard to lapse behavior. Relations among general psychological maladjustment, withdrawal-like symptoms, and lapse were significant in both abstinent and nonabstinent conditions, suggesting that psychological maladjustment, and not nicotine withdrawal per se, accounted for the relation with lapse. These results highlight the potential for smoking-cessation strategies that target general psychological maladjustment processes and have implications for addressing withdrawal-like symptoms among individuals with psychological symptoms. (c) 2015 APA, all rights reserved).

Entities:  

Mesh:

Year:  2014        PMID: 25243836      PMCID: PMC4407813          DOI: 10.1037/adb0000029

Source DB:  PubMed          Journal:  Psychol Addict Behav        ISSN: 0893-164X


  54 in total

Review 1.  Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal.

Authors:  S S Watkins; G F Koob; A Markou
Journal:  Nicotine Tob Res       Date:  2000-02       Impact factor: 4.244

Review 2.  Addiction motivation reformulated: an affective processing model of negative reinforcement.

Authors:  Timothy B Baker; Megan E Piper; Danielle E McCarthy; Matthew R Majeskie; Michael C Fiore
Journal:  Psychol Rev       Date:  2004-01       Impact factor: 8.934

3.  Patterns of depressive symptomatology in women smokers, ex-smokers, and never-smokers.

Authors:  Cynthia S Pomerleau; Alyssa N Zucker; Abigail J Stewart
Journal:  Addict Behav       Date:  2003-04       Impact factor: 3.913

4.  Effects of anhedonia on days to relapse among smokers with a history of depression: a brief report.

Authors:  Jessica Cook; Bonnie Spring; Dennis McChargue; Neal Doran
Journal:  Nicotine Tob Res       Date:  2010-08-13       Impact factor: 4.244

5.  Reduced facial expression and social context in major depression: discrepancies between facial muscle activity and self-reported emotion.

Authors:  J Gehricke; D Shapiro
Journal:  Psychiatry Res       Date:  2000-08-21       Impact factor: 3.222

6.  Who gets what symptom? Effects of psychiatric cofactors and nicotine dependence on patterns of smoking withdrawal symptomatology.

Authors:  C S Pomerleau; J L Marks; O F Pomerleau
Journal:  Nicotine Tob Res       Date:  2000-08       Impact factor: 4.244

7.  Nicotine withdrawal among adolescents with acute psychopathology: an item response analysis.

Authors:  David R Strong; Christopher W Kahler; Susan E Ramsey; Ana Abrantes; Richard A Brown
Journal:  Nicotine Tob Res       Date:  2004-06       Impact factor: 4.244

8.  Symptoms of tobacco withdrawal. A replication and extension.

Authors:  J R Hughes; S W Gust; K Skoog; R M Keenan; J W Fenwick
Journal:  Arch Gen Psychiatry       Date:  1991-01

9.  Signs and symptoms of tobacco withdrawal.

Authors:  J R Hughes; D Hatsukami
Journal:  Arch Gen Psychiatry       Date:  1986-03

10.  Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse.

Authors:  Mustafa al'Absi; Dorothy Hatsukami; Gary L Davis; Lorentz E Wittmers
Journal:  Drug Alcohol Depend       Date:  2004-03-08       Impact factor: 4.492

View more
  5 in total

1.  Happiness as a Buffer of the Association Between Dependence and Acute Tobacco Abstinence Effects in African American Smokers.

Authors:  Madalyn M Liautaud; Adam M Leventhal; Raina D Pang
Journal:  Nicotine Tob Res       Date:  2018-09-04       Impact factor: 4.244

2.  Drug and alcohol dependence acute effects of pod-style e-cigarettes in vaping-naïve smokers.

Authors:  Natalia Peraza; Mariel S Bello; Sara J Schiff; Junhan Cho; Yi Zhang; Carly Callahan; Alayna Tackett; Adam M Leventhal
Journal:  Drug Alcohol Depend       Date:  2021-09-21       Impact factor: 4.492

3.  Associations Between Smoking Abstinence, Inhibitory Control, and Smoking Behavior: An fMRI Study.

Authors:  Spencer Bell; Brett Froeliger
Journal:  Front Psychiatry       Date:  2021-04-01       Impact factor: 4.157

4.  Anhedonia in tobacco withdrawal among African-American smokers.

Authors:  Madalyn M Liautaud; Afton Kechter; Mariel S Bello; Casey R Guillot; Jason A Oliver; Devin E Banks; Lina M D'Orazio; Adam M Leventhal
Journal:  Exp Clin Psychopharmacol       Date:  2021-06-10       Impact factor: 3.492

5.  Association of frequency of perceived exposure to discrimination with tobacco withdrawal symptoms and smoking lapse behavior in African Americans.

Authors:  Mariel S Bello; Madalyn M Liautaud; Julianne T De La Cerda; Raina D Pang; Lara A Ray; Jasjit A Ahluwalia; Adam M Leventhal
Journal:  Addiction       Date:  2020-10-01       Impact factor: 7.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.